This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Gc Cell Corporation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Mi Young Jung: Innovator in Chimeric Antigen Receptor Technology
Introduction
Mi Young Jung is a prominent inventor based in Yongin-si, South Korea. She has made significant contributions to the field of immunotherapy, particularly through her work on chimeric antigen receptors (CARs). Her innovative approach aims to enhance the anticancer activity of immune cells, providing new avenues for cancer treatment.
Latest Patents
Mi Young Jung holds a patent for a chimeric antigen receptor and natural killer cells expressing the same. This invention includes an intracellular signaling domain that incorporates the whole or a portion of an OX40 ligand (CD252). The technology demonstrates excellent effects in increasing the anticancer activity of immune cells, showcasing its potential in therapeutic applications.
Career Highlights
Mi Young Jung is affiliated with Gc Cell Corporation, where she continues to advance her research in immunotherapy. Her work has positioned her as a key figure in the development of innovative cancer treatments.
Collaborations
Some of her notable coworkers include Yu Kyeong Hwang and Sung Yoo Cho, who collaborate with her in various research initiatives.
Conclusion
Mi Young Jung's contributions to the field of immunotherapy through her innovative patent highlight her role as a leading inventor in cancer treatment technology. Her work continues to inspire advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile